Archive | September, 2015

Biotech Bear Market Trends #5: Update-3

Another Rally from FED minutes…except biotech 10/8/15 … BIOTECH-Another test near 2015 lows in early AM ; choppy downtrend but look for a bottoming process as market is turning up toward close: IBB at 306 down slightly after reversal XBI down 1.7% to 63.3 XLV now green 10/5  9 AM …Rally Should Continue for Third […]

Continue Reading 0

Biotech Bull Market: Trends to Watch #4

After the close 9/25…The bio-bubble has burst. XBI down 6.85%, IBB down 4.91%. Can healthcare sector recover? —– Bull Market Intact But Sentiment Has Turned Negative The severe 20%++ correction in the biotech sector is getting a lot of bearish commentary particularly after the Hilary “price gouging” Tweet. Here are the Five Trends in Biotech […]

Continue Reading 0

Biotech Stocks Crushed on Drug Pricing Issue: Caution…Update-1

Update-1… 9/22/15 …Biotech Stocks Trade Down Another Day  Biotech stocks were weak tracking NASDAQ which was down 1.5%. The IBB was down 1.49% to $335.40 flat over one month and up 10.57% YTD. The August low was $325 and the IBB is 16% off July 20 highs. The small cap weighted XBI was down 2.29% […]

Continue Reading 0

Rayno Life Sciences Diagnostics and Tools Update: Volatile Stocks and Slower Growth Ahead

10/7/15 Update…Still in No Man’s Land…Nothing to Do See recent posts on bear market in biotech. We need to wait for Q3 earnings to find trades and longer term value in Dx and Tools. Most stocks in the sector have been hit hard since August. ———- Slower Growth with Same Themes: Sequencing (NGS) and Molecular […]

Continue Reading 0

Biotech ETFs in A Bull Market: Positioning for a Q4 Rally… Part 2..Update

Update-1… 3P September 17 after FED Says No Rate Hike-Biotechs Rally NASDAQ up 0.8% after initial surge Apparently biotech stocks are sensitive to interest rate hikes as many analysts have suggested. Biotech companies need a continual inflow of capital and would be sensitive to higher interest rates. An analyst came on CNBC this AM suggesting […]

Continue Reading 0

Biotech ETFs Up YTD But 12% Losses in August Creates Downtrend…Update-2.. 9/4

Update -2… 9/8 Rally Time Today Forecasted by Friday’s Action ETF Summary -One month and YTD % FBT (12.36), +9.2% IBB (8.9), +11.3% XBI (10.12), +17.27% The five star Fidelity Select Biotech Portfolio (FBIOX) pretty much tracks the IBB up 11.66% YTD and down (8.52) for one month. Three relatively new top ten mid-cap holdings […]

Continue Reading 0